1-13 of 13
Elisabetta Patorno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study

Available to Purchase
Alexander Kutz, Dae Hyun Kim, Jun Liu, Medha N. Munshi, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2025;48(3):455–463
https://doi.org/10.2337/dc24-1795
Published: 02 January 2025
View articletitled, Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study
Open the PDF for Prescribing Trends of Glucose-Lowering Medications Near End of Life Among Adults With Type 2 Diabetes: A Cohort Study in another window
Journal Articles

Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus

Available to Purchase
Jennifer J. Yland, Krista F. Huybrechts, Amelia K. Wesselink, Loreen Straub, Yu-Han Chiu, Ellen W. Seely, Elisabetta Patorno, Brian T. Bateman, Helen Mogun, Lauren A. Wise, Sonia Hernández-Díaz
Journal: Diabetes Care
Diabetes Care 2024;47(9):1688–1695
https://doi.org/10.2337/dc23-2056
Published: 23 July 2024
View articletitled, Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus
Open the PDF for Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes Mellitus in another window
Journal Articles

Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes

Available to Purchase
Phyo Than Htoo, Mehdi NajafZadeh, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Robert J. Glynn, Niklas Schmedt, Anouk Déruaz-Luyet, Lisette Koeneman, Julie M. Paik, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2024;47(11):1900–1907
https://doi.org/10.2337/dc24-0270
Published: 25 June 2024
View articletitled, Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes
Open the PDF for Health Care Utilization and Costs Associated With Empagliflozin in Older Adults With Type 2 Diabetes in another window
Journal Articles

Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes

Free
Alexander Kutz, Dae Hyun Kim, Deborah J. Wexler, Jun Liu, Sebastian Schneeweiss, Robert J. Glynn, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2023;46(11):2004–2014
https://doi.org/10.2337/dc23-0671
Published: 07 September 2023
View articletitled, Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
Open the PDF for Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes in another window
Journal Articles

Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes

Free
Edward W. Gregg, Elisabetta Patorno, Andrew J. Karter, Roopa Mehta, Elbert S. Huang, Martin White, Chirag J. Patel, Allison T. McElvaine, William T. Cefalu, Joseph Selby, Matthew C. Riddle, Kamlesh Khunti
Journal: Diabetes Care
Diabetes Care 2023;46(7):1316–1326
https://doi.org/10.2337/dc22-1438
Published: 20 June 2023
View articletitled, Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes
Open the PDF for Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes in another window
Journal Articles

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure

Free
Sara J. Cromer, Julie C. Lauffenburger, Raisa Levin, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2023;46(1):65–74
https://doi.org/10.2337/dc22-0383
Published: 16 November 2022
View articletitled, Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure
Open the PDF for Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study

Free
Devin Abrahami, Helen Tesfaye, Hui Yin, Seanna Vine, Blánaid Hicks, Oriana H.Y. Yu, Lysanne Campeau, Robert W. Platt, Sebastian Schneeweiss, Elisabetta Patorno, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2022;45(12):2907–2917
https://doi.org/10.2337/dc22-1174
Published: 28 September 2022
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study in another window
Journal Articles

Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries

Free
Chelsea E. Hawley, Julie C. Lauffenburger, Julie M. Paik, Deborah J. Wexler, Seoyoung C. Kim, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2022;45(3):604–613
https://doi.org/10.2337/dc21-1676
Published: 18 January 2022
View articletitled, Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries
Open the PDF for Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries in another window
Journal Articles

Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Cohort Study

Free
Samantha T. Harris, Elisabetta Patorno, Min Zhuo, Seoyoung C. Kim, Julie M. Paik
Journal: Diabetes Care
Diabetes Care 2021;44(10):2293–2301
https://doi.org/10.2337/dc21-0529
Published: 03 August 2021
View articletitled, Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Cohort Study
Open the PDF for Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Cohort Study in another window
Journal Articles

Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA

Free
HoJin Shin, Sebastian Schneeweiss, Robert J. Glynn, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2021;44(8):1774–1782
https://doi.org/10.2337/dc20-2926
Published: 18 June 2021
View articletitled, Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA
Open the PDF for Trends in First-Line Glucose-Lowering Drug Use in Adults With Type 2 Diabetes in Light of Emerging Evidence for SGLT-2i and GLP-1RA in another window
Journal Articles

Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults

Free
Elisabetta Patorno, Ajinkya Pawar, Lily G. Bessette, Dae H. Kim, Chintan Dave, Robert J. Glynn, Medha N. Munshi, Sebastian Schneeweiss, Deborah J. Wexler, Seoyoung C. Kim
Journal: Diabetes Care
Diabetes Care 2021;44(3):826–835
https://doi.org/10.2337/dc20-1464
Published: 11 February 2021
View articletitled, Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults
Open the PDF for Comparative Effectiveness and Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults in another window
Journal Articles

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018

Free
Chintan V. Dave, Sebastian Schneeweiss, Deborah J. Wexler, Gregory Brill, Elisabetta Patorno
Journal: Diabetes Care
Diabetes Care 2020;43(4):921–924
https://doi.org/10.2337/dc19-1943
Published: 10 February 2020
View articletitled, Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018
Open the PDF for Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018 in another window
Includes: Supplementary data
Journal Articles

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride

Free
Elisabetta Patorno, Sebastian Schneeweiss, Chandrasekar Gopalakrishnan, David Martin, Jessica M. Franklin
Journal: Diabetes Care
Diabetes Care 2019;42(12):2204–2210
https://doi.org/10.2337/dc19-0069
Published: 11 July 2019
View articletitled, Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride
Open the PDF for Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride in another window
Includes: Supplementary data